Ferric carboxymaltose comparable to oral iron supplementation for pregnant women with anemia

1. Although anemia prevalence at 36 weeks was slightly lower in the ferric carboxymaltose group compared to standard-of-care, statistical significance was not achieved. 2. Adverse events between both groups were comparable; there were no changes in birth weight. Evidence Rating Level: 1 (Excellent) Study Rundown: Anemia affects more than one-third of all pregnancies in Africa.

Related Keywords

Malawi ,Bangladesh ,Malawian , ,Rating Level ,Iron Interventions ,Between Nov ,Anemia ,Ferric Carboxymaltose ,Iron Deficiency Anemia ,Iron Supplementation ,Women 039s Health ,Chronic Disease ,Obstetrics ,